Bafna Pharmaceuticals Ltd 12 Oct 2026 12:00 AM
Bafna Pharmaceuticals submitted a regulatory filing to BSE and NSE for the September quarter,
BAFNA PHARMACEUTICALS LIMITED submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 12, 2026, concerning Regulation 74(5) of the SEBI (Depositories And Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by its Registrar and Share Transfer Agent, CAMEO CORPORATE SERVICES LIMITED.
Bafna Pharmaceuticals Ltd 26 Sep 2026 12:00 AM
Bafna Pharmaceuticals halts trading for insiders pending quarterly results declaration,
BAFNA PHARMACEUTICALS LIMITED will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Bafna Pharmaceuticals Ltd 13 Aug 2026 12:00 AM
Bafna Pharmaceuticals schedules its 31st Annual General Meeting for September 11, 2026, via video conference,
BAFNA PHARMACEUTICALS LIMITED will hold its 31st Annual General Meeting on Friday, September 11, 2026, at 10:00 A.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), with the Register of Members and Share Transfer Books closed from Saturday, September 05, 2026 to Friday, September 11, 2026, and has engaged Central Depository Services (India) Limited (“CDSL”) for providing E-Voting services.
Bafna Pharmaceuticals Ltd 06 Aug 2026 12:00 AM
Bafna Pharmaceuticals to table results,
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 August 2026.
Bafna Pharmaceuticals Ltd 30 May 2026 12:00 AM
Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter,
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales42.2439.06 8 150.62145.86 3 OPM %8.407.96 -10.587.66 - PBDT4.283.32 29 17.0411.19 52 PBT2.623.10 -15 10.976.30 74 NP2.751.31 110 11.104.15 167 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now